Annual Current Assets
$182.94 M
-$54.17 M-22.85%
December 31, 2023
Summary
- As of February 24, 2025, CTMX annual total current assets is $182.94 million, with the most recent change of -$54.17 million (-22.85%) on December 31, 2023.
- During the last 3 years, CTMX annual current assets has fallen by -$141.08 million (-43.54%).
- CTMX annual current assets is now -58.93% below its all-time high of $445.48 million, reached on December 31, 2018.
Performance
CTMX Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Assets
$124.18 M
-$18.90 M-13.21%
September 30, 2024
Summary
- As of February 24, 2025, CTMX quarterly total current assets is $124.18 million, with the most recent change of -$18.90 million (-13.21%) on September 30, 2024.
- Over the past year, CTMX quarterly current assets has dropped by -$77.02 million (-38.28%).
- CTMX quarterly current assets is now -73.72% below its all-time high of $472.51 million, reached on September 30, 2018.
Performance
CTMX Quarterly Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Assets Formula
Current Assets = Cash and Equivalents + Accounts Receivable + Inventory + Prepaid Expenses + Marketable Securities + Other Current Assets
CTMX Current Assets Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -22.9% | -38.3% |
| 3 y3 years | -43.5% | -38.3% |
| 5 y5 years | -58.9% | -38.3% |
CTMX Current Assets Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -41.0% | at low | -60.0% | at low |
| 5 y | 5-year | -43.5% | at low | -69.0% | at low |
| alltime | all time | -58.9% | +1874.3% | -73.7% | +85.8% |
CytomX Therapeutics Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $124.18 M(-13.2%) |
| Jun 2024 | - | $143.08 M(-14.4%) |
| Mar 2024 | - | $167.25 M(-8.6%) |
| Dec 2023 | $18.86 M(-20.7%) | $182.94 M(-9.1%) |
| Sep 2023 | - | $201.20 M(+7.1%) |
| Jun 2023 | - | $187.80 M(-11.5%) |
| Mar 2023 | - | $212.28 M(-10.5%) |
| Dec 2022 | $23.79 M(-18.3%) | $237.10 M(+18.4%) |
| Sep 2022 | - | $200.28 M(-14.0%) |
| Jun 2022 | - | $232.77 M(-13.3%) |
| Mar 2022 | - | $268.44 M(-13.5%) |
| Dec 2021 | $29.11 M(-16.0%) | $310.30 M(+28.8%) |
| Sep 2021 | - | $241.00 M(-11.1%) |
| Jun 2021 | - | $271.00 M(-32.3%) |
| Mar 2021 | - | $400.01 M(+23.5%) |
| Dec 2020 | $34.65 M(-8.7%) | $324.01 M(-4.8%) |
| Sep 2020 | - | $340.31 M(-7.2%) |
| Jun 2020 | - | $366.57 M(-8.4%) |
| Mar 2020 | - | $400.07 M(+31.9%) |
| Dec 2019 | $37.95 M | $303.33 M(-9.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2019 | - | $334.78 M(-8.7%) |
| Jun 2019 | - | $366.68 M(-9.5%) |
| Mar 2019 | - | $405.08 M(-9.1%) |
| Dec 2018 | $11.63 M(+28.6%) | $445.48 M(-5.7%) |
| Sep 2018 | - | $472.51 M(+28.9%) |
| Jun 2018 | - | $366.67 M(-0.1%) |
| Mar 2018 | - | $367.03 M(-5.6%) |
| Dec 2017 | $9.04 M(-17.6%) | $388.60 M(+3.2%) |
| Sep 2017 | - | $376.37 M(+10.5%) |
| Jun 2017 | - | $340.68 M(+104.1%) |
| Mar 2017 | - | $166.91 M(-11.3%) |
| Dec 2016 | $10.98 M(+47.2%) | $188.15 M(+2.6%) |
| Sep 2016 | - | $183.31 M(-8.2%) |
| Jun 2016 | - | $199.61 M(+8.2%) |
| Mar 2016 | - | $184.55 M(-2.7%) |
| Dec 2015 | $7.46 M(+20.2%) | $189.75 M(+64.9%) |
| Sep 2015 | - | $115.07 M(-9.6%) |
| Jun 2015 | - | $127.26 M(+90.4%) |
| Dec 2014 | $6.21 M(+26.3%) | $66.85 M |
| Dec 2013 | $4.92 M | - |
FAQ
- What is CytomX Therapeutics annual total current assets?
- What is the all time high annual current assets for CytomX Therapeutics?
- What is CytomX Therapeutics annual current assets year-on-year change?
- What is CytomX Therapeutics quarterly total current assets?
- What is the all time high quarterly current assets for CytomX Therapeutics?
- What is CytomX Therapeutics quarterly current assets year-on-year change?
What is CytomX Therapeutics annual total current assets?
The current annual current assets of CTMX is $182.94 M
What is the all time high annual current assets for CytomX Therapeutics?
CytomX Therapeutics all-time high annual total current assets is $445.48 M
What is CytomX Therapeutics annual current assets year-on-year change?
Over the past year, CTMX annual total current assets has changed by -$54.17 M (-22.85%)
What is CytomX Therapeutics quarterly total current assets?
The current quarterly current assets of CTMX is $124.18 M
What is the all time high quarterly current assets for CytomX Therapeutics?
CytomX Therapeutics all-time high quarterly total current assets is $472.51 M
What is CytomX Therapeutics quarterly current assets year-on-year change?
Over the past year, CTMX quarterly total current assets has changed by -$77.02 M (-38.28%)